DIABETIC CARDIOMYOPATHY. RESISTIN: A CONTROL OF A MYOCARDIAL HYPERTROPHY

Aim. To evaluate the association of serum resistin with morphological and functional indices of hypertrophic myocardium in patients with type 2 diabetes and chronic heart failure (CHF) with preserved left ventricular ejection fraction.Material and methods. Patients (n=60; 12 men and 48 women) with t...

ver descrição completa

Detalhes bibliográficos
Principais autores: An. A. Aleksandrov, O. A. Shatskaya, S. S. Kuharenko, M. N. Yadrihinskaya, E. N. Abdalkina, E. N. Drozdova, M. V. Shestakova
Formato: Artigo
Idioma:English
Publicado em: Столичная издательская компания 2015-09-01
coleção:Рациональная фармакотерапия в кардиологии
Assuntos:
Acesso em linha:https://www.rpcardio.online/jour/article/view/214